Bolus Intrathecal Injection of Ziconotide (Prialt®) to Evaluate the Option of Continuous Administration via an Implanted Intrathecal Drug Delivery (ITDD) System: A Pilot Study
1. James Cook University Hospital, , Middlesbrough, UK;2. Leeds Teaching Hospital Trust, , Leeds, UK;3. Ensemble Hospitalier de la C?te (EHC), , Morges, Switzerland;4. Teesside University, Health and Social Care Institute, , UK